The company had posted a net profit of Rs 40 crore in the corresponding period of the previous fiscal, Dr Lal PathLabs said in a BSE filing.
Consolidated total income of the company also rose to Rs 256.8 crore for the quarter under consideration as against Rs 229.2 crore for the same period a year ago.
Shares of Dr Lal PathLabs were today trading at Rs 831.60 per scrip in the afternoon trade on BSE, up 1.96 per cent from its previous close.